Syra Health Business Summary

Syra Health Corp (SYRA) operates as an integrated healthcare solutions provider, generating revenue through high-value service contracts with state and local government agencies, managed care organizations, and private insurance providers. The company’s business model is structured across five primary segments: Population Health, Behavioral and Mental Health, Digital Health, Health Education, and Healthcare Workforce. Recently, the firm has strategically pivoted toward its higher-margin Population Health and Digital Health units—featuring proprietary tools like the Syrenity mental health app and the SyraBot AI chatbot—while deprioritizing lower-margin staffing contracts. Within the competitive landscape, Syra Health contends with larger-scale entities such as Indegene, AMN Healthcare, IntegriChain, and American Well Corp (AMWL). As a micro-cap player recently transitioned to the OTCQB market, Syra Health differentiates itself by offering niche, prevention-focused analytics and localized mental health wraparound services that cater to specific public sector mandates. The company was founded by Feroz Syed, Dr. Deepika Vuppalanchi, and the late Sandeep Allam. Leadership is currently spearheaded by CEO Gregory R. Alexander, who assumed the role in January 2026; Alexander is a former U.S. Marine Corps officer with over 20 years of healthcare executive experience at Lumeris, CitizensRx, and Ellipsis Health. Supporting him is Priya Prasad, who serves as both Chief Financial Officer and Chief Operating Officer, bringing a two-decade pedigree in finance and operations from her tenure as President of STLogics. The Board of Directors is chaired by Andrew Dahlem and includes notable members such as Ketan Paranjape, a former executive at Optum and Roche Diagnostics, and Dr. Avutu Reddy of Corteva Agriscience. Institutional backing includes Warberg Asset Management, reflecting the company's ongoing efforts to scale its digital health portfolio and stabilize its capital structure following its 2023 IPO.